Minocycline
مینوسایکلین
🦠 Antiinfectives For Systemic UseTetracycline antibiotic
Market / country: 🇺🇸 USA
Minocin (US)
🧮 Dose calculator
Susceptible bacterial infections (general) · Regimen source: FDA Minocycline caps. · Dosage and Administration — Adults
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to tetracyclines. FDA Minocycline caps. · Contraindications
- ⚠️ Under 8 years (permanent tooth discoloration). FDA Minocycline caps. · Warnings
Formulations
- 50 mg capsule — capsule 🇺🇸 USA FDA Minocycline caps. · How Supplied
- 75 mg capsule — capsule 🇺🇸 USA FDA Minocycline caps. · How Supplied
- 100 mg capsule — capsule 🇺🇸 USA FDA Minocycline caps. · How Supplied
👥 Special populations
- 🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Minocycline caps. · Precautions/Warnings – Pregnancy
“Minocycline, like other tetracycline-class antibiotics, crosses the placenta and may cause fetal harm when administered to a pregnant woman.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Minocycline caps. · Precautions/Warnings – Nursing Mothers
“Tetracyclines are excreted in human milk.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Minocycline caps. · Precautions/Warnings – Pediatric Use
“Minocycline is not recommended for the use in children below 8 years of age unless the expected benefits of therapy outweigh the risks (see WARNINGS ).”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Minocycline caps. · Precautions/Warnings – Geriatric Use
“In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy (see WARNINGS and”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA063181
- DailyMed (FDA label)FDA Minocycline caps.
- MedlinePlus (NIH)MinocyclineMinocycline Topical
- WHO ATC/DDDJ01AA08
- Darooyab (Iran)Minocycline
🇮🇷 Registered in Iran Darooyab · G-442/Minocycline
Dosage forms with Iranian generic codes, per Darooyab.
- 15238 · MINOCYCLINE 100MG CAP · کپسول مینوسایکلین ۱۰۰ میلیگرم
- 06460 · MINOCYCLINE 100MG TAB · قرص مینوسایکلین ۱۰۰ میلیگرم
- 15893 · MINOCYCLINE 50MG CAP · کپسول مینوسایکلین ۵۰ میلیگرم
- 12107 · MINOCYCLINE 50MG TAB · قرص مینوسایکلین ۵۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Minocycline caps. · How SuppliedFDA Minocycline caps. · Dosage and Administration — AdultsFDA Minocycline caps. · Dosage and AdministrationFDA Minocycline caps. · ContraindicationsFDA Minocycline caps. · WarningsFDA Minocycline caps. · Precautions/Warnings – PregnancyFDA Minocycline caps. · Precautions/Warnings – Nursing MothersFDA Minocycline caps. · Precautions/Warnings – Pediatric UseFDA Minocycline caps. · Precautions/Warnings – Geriatric UseFDA Minocycline caps. · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-442/Minocycline
- Clinical review⚠ Unverified